Trans Genic Inc (2342)

Currency in JPY
201.0
0.0(0.00%)
Closed·
2342 Scorecard
Full Analysis
Prominent player in the Biotechnology industry
Earnings results expected in 7 days
2342 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
200.0205.0
52 wk Range
130.0261.0
Key Statistics
Bid/Ask
201.00 / 202.00
Prev. Close
201
Open
200
Day's Range
200-205
52 wk Range
130-261
Volume
162.8K
Average Volume (3m)
671.27K
1-Year Change
-12.12%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2342 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low revenue valuation multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Trans Genic Inc Company Profile

Transgenic Group Inc. develops, distributes, and licenses genetically modified animals and antibodies in Japan. It operates through Drug Discovery Support Business and Investment Business segments. The company provides glycan synthesis and analysis services; non-clinical studies for pharmaceuticals, foods, cosmetics, chemical substances, etc., as well as various safety tests for foods, and pharmaceutical agents; and support for bioequivalence test, including clinical trials, pharmacokinetic measurements, and the preparation of clinical trial reports; as well as hospital support services. It also offers drug efficiency and pharmacological test and safety studies; sugar chain analysis and synthesis services; advice and support services, including M&A, business revitalization, business succession services; and contract production services, such as genetically modified mice, antibodies, protein hypers, and expressing cells, as well as sells mouse-related products and mouse models, and research reagents. The company was formerly known as Trans Genic Inc. and changed its name to Transgenic Group Inc. in October 2024. Transgenic Group Inc. was incorporated in 1998 and is headquartered in Fukuoka City, Japan.

Employees
241
Market
Japan

Compare 2342 to Peers and Sector

Metrics to compare
2342
Peers
Sector
Relationship
P/E Ratio
−3.1x−6.2x−0.5x
PEG Ratio
0.00−0.200.00
Price/Book
0.7x4.8x2.6x
Price / LTM Sales
0.3x48.9x3.3x
Upside (Analyst Target)
-73.8%43.5%
Fair Value Upside
Unlock9.5%6.9%Unlock

Earnings

Latest Release
Jun 16, 2025
EPS / Forecast
-47.97 / --
Revenue / Forecast
3.20B / --
EPS Revisions
Last 90 days

2342 Income Statement

FAQ

What Stock Exchange Does Trans Genic Trade On?

Trans Genic is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for Trans Genic?

The stock symbol for Trans Genic is "2342."

What Is the Trans Genic Market Cap?

As of today, Trans Genic market cap is 3.40B.

What Is Trans Genic's Earnings Per Share (TTM)?

The Trans Genic EPS (TTM) is -65.47.

When Is the Next Trans Genic Earnings Date?

Trans Genic will release its next earnings report on 13 Aug 2025.

From a Technical Analysis Perspective, Is 2342 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Trans Genic Stock Split?

Trans Genic has split 2 times.

How Many Employees Does Trans Genic Have?

Trans Genic has 241 employees.

What is the current trading status of Trans Genic (2342)?

As of 07 Aug 2025, Trans Genic (2342) is trading at a price of 201.00, with a previous close of 201.00. The stock has fluctuated within a day range of 200.00 to 205.00, while its 52-week range spans from 130.00 to 261.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.